FDA Approved: GALAFOLD — Supplemental Application (Amicus Therapeutics US, LLC)

View source ↗

Summary

FDA approved a supplemental application for GALAFOLD (migalastat hydrochloride) by Amicus Therapeutics US, LLC, resulting in labeling updates for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• GALAFOLD (MIGALASTAT HYDROCHLORIDE)

Snippet

SUPPL AP for GALAFOLD (MIGALASTAT HYDROCHLORIDE)